This federal contract award, with ID SPE2DB22D1202|SPE2DB25FUMN9, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4566708828 - DUPIXENT 300 MG/2 ML SYRINGE 2ML. The contract has a ceiling value of $53,401.34 and was awarded on December 12, 2024, with an ultimate completion date of December 13, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there is no set-aside designation.
AmerisourceBergen Drug Corp, a for-profit organization, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.
Generated 3/13/25, 9:53 AM